← FDA DRUG APPROVALS

FDA ANDA · ANDA073034

METAPROTERENOL SULFATE

Sponsor: G AND W LABS INC

APPLICATION
ANDA073034
TYPE
ANDA
ORIGINAL APPROVAL
1991-08-30
LATEST ACTION
1999-03-23
ROUTE
ORAL
DOSAGE FORM
SYRUP
MARKETING STATUS
Discontinued

Products

METAPROTERENOL SULFATEDiscontinued
METAPROTERENOL SULFATE 10MG/5ML · SYRUP · ORAL

Approval history

1999-03-23Manufacturing (CMC) · Supplement 4AP
1996-05-31Manufacturing (CMC) · Supplement 3AP
1992-12-03Manufacturing (CMC) · Supplement 1AP
1992-10-08Labeling · Supplement 2AP
1991-08-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →